Research and Development
A Randomized,Double-Blind, Single-Dose Study Comparing the Biosimilarity of HOT-1010 with Bevacizumab (Avastin®) in Chinese Healthy Male Subjects
Original Research Article:
Frontiers in Pharmacology
http://doi: 10.3389/fphar.2021.694375